Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
---|
10/01/2013 | US8546403 Compounds that modulate intracellular calcium |
09/26/2013 | WO2013139206A1 3-oxo-3,4-dihydro-2-pyrazine-formamide derivative, pharmaceutical composition of same, method for preparing same, and use thereof |
09/26/2013 | US20130252974 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin ii receptor antagonists |
09/26/2013 | DE10321565B4 Verfahren zur Herstellung von Alkyldihydro-1,4-diazinen und Alkyl-1,4-diazinen A process for preparing Alkyldihydro-1,4-diazines, and alkyl-1,4-diazines |
09/25/2013 | EP2640507A1 Acid gas absorbent composition |
09/24/2013 | US8541579 Substituted diketopiperazines as oxytocin antagonists |
09/24/2013 | US8541578 Process for the production of n-(2,6-dimethyl-phenyl)-2-piperazin-1-yl-acetamide |
09/24/2013 | US8541572 Compounds for the treatment of inflammatory disorders |
09/24/2013 | US8541415 Targeting an HIV-1 nef-host cell kinase complex |
09/24/2013 | US8541406 Thiadiazole derivatives for the treatment of neurodegenerative diseases |
09/19/2013 | WO2013137832A1 Myostatin inhibitors |
09/19/2013 | WO2013137479A1 Decahydroquinoxaline derivatives and analogs thereof |
09/19/2013 | US20130245264 Pyrazino[2,3-d]isoxazole derivative |
09/19/2013 | US20130245034 Inhibitors Of Histone Deacetylase |
09/19/2013 | US20130244995 Calcium-sensing receptor-active compounds |
09/18/2013 | EP2639235A1 Pyrazino[2,3-d]isooxazole derivative |
09/18/2013 | EP2639216A1 Halogenated indenones and method for producing optically active indanones or optically active indanols by using same |
09/18/2013 | EP2638181A1 Non metal tanning |
09/18/2013 | EP2638036A1 Compound for increasing kinase active and application thereof |
09/18/2013 | EP2638019A1 Herbicidal compounds |
09/18/2013 | CN103304496A Method for synthesizing phenazine-1-carboxylic acid |
09/18/2013 | CN103304495A Preparation method and applications of olaquindox metabolite hapten |
09/18/2013 | CN103304494A Indene (1,2-b) quinoxaline-11-ketoxime derivatives and preparation method as well as application thereof |
09/18/2013 | CN103304428A Amine-based compound, organic light-emitting diode including the same, and organic light-emitting apparatus including the amine-based compound |
09/17/2013 | US8536184 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof |
09/17/2013 | US8536178 Pharmaceutical composition for preventing or treating diseases associated with beta-amyloid accumulation containing morpholin or piperazine based compounds having SO3H or COOH as active ingredient |
09/17/2013 | CA2570903C N-hydroxyamide derivatives and use thereof |
09/12/2013 | WO2013134061A1 Phenicol antibacterials |
09/12/2013 | WO2013131978A1 Process for the preparation of intermediates useful in the preparation of a viral protease inhibitor |
09/12/2013 | WO2013084214A3 Pyrazinoic acid prodrugs activated by esterases of mycobacteria |
09/12/2013 | US20130237529 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses |
09/12/2013 | US20130237528 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
09/11/2013 | CN103298786A Salts of arylsulfonamide ccr3 antagonists |
09/11/2013 | CN103288764A Quinhydroxy ketone glycine ester hydrochloride and preparation method thereof |
09/11/2013 | CN103288763A Industrial production method of 2,6-dichloropyrazine |
09/11/2013 | CN103288752A Cinnamic amide derivatives, their preparation methods and their application in preparation of bleeding stopping and stasis dissolving medicines |
09/11/2013 | CN102329272B Method for preparing quinocetone |
09/10/2013 | US8530673 Tetrathiafulvalene derivative, and organic film and organic transistor using the same |
09/10/2013 | US8530658 Carbazole derivative with heteroaromatic ring, and light-emitting element, light-emitting device, and electronic device using carbazole derivative with heteroaromatic ring |
09/10/2013 | US8530469 Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90 |
09/10/2013 | US8529796 Charge transport compositions and electronic devices made with such compositions |
09/06/2013 | WO2013059433A3 Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer |
09/05/2013 | US20130231479 Aryloxyurea compound and pest control agent |
09/05/2013 | US20130231351 Sir2 regulation |
09/05/2013 | US20130231342 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use |
09/05/2013 | US20130231319 Bridged Spiro[2.4]heptane Ester Derivatives |
09/04/2013 | EP2632465A1 Inhibitors of the renal outer medullary potassium channel |
09/04/2013 | CN203170326U Reaction kettle for preparing acetylpyrazine |
09/04/2013 | CN103275021A N-dichloracetyl-6, 7-dichloro-1, 2, 3, 4-tetrahydro quinoxaline and preparation method thereof |
09/04/2013 | CN102225913B Rheinic acid derivatives and treatment application thereof |
09/04/2013 | CN102066342B Quinoxalinedione derivatives |
09/04/2013 | CN101374820B Piperazine compounds with a herbicidal action |
09/03/2013 | US8524717 Oxidase inhibitors and their use |
09/03/2013 | US8524714 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors |
09/03/2013 | US8524711 Amino-derivatives as novel inhibitors of histone deacetylase |
09/03/2013 | CA2572153C Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes |
08/29/2013 | US20130225587 Compound for increasing kinase active and application thereof |
08/29/2013 | US20130224882 Assay for the Detection of the Phenylpiperazine Family |
08/29/2013 | DE102012202782A1 Neue Oxidationsfarbstoffvorprodukte Last oxidation dye precursors |
08/28/2013 | EP2631229A1 P2x4 receptor antagonist |
08/28/2013 | EP2630130A1 Method for preparing substituted n-(3-amino-quinoxalin-2-yl)-sulfonamides and their intermediates n-(3-chloro-quinoxalin-2-yl)sulfonamides |
08/28/2013 | EP2630129A1 Quinoxaline derivates |
08/28/2013 | CN103270027A Method for preparing substituted n-3-amino-quinoxalin-<wbr/>2-yl)-sulfonamides and their intermediates n-<wbr/>(3-chloro-quinoxalin-<wbr/>2-yl)sulfonamides |
08/28/2013 | CN103265498A Novel technology for trans-2,6-lupetazin |
08/28/2013 | CN101812026B Method for synthesizing bortezomib |
08/27/2013 | US8519127 Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy |
08/22/2013 | WO2013121387A1 Anti -malarial agents |
08/22/2013 | US20130217708 Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide |
08/22/2013 | US20130217706 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
08/22/2013 | US20130217687 Arylsulfonamide ccr3 antagonists |
08/22/2013 | US20130217670 Quinoxaline derivatives |
08/22/2013 | US20130217660 Novel prolylcarboxypeptidase inhibitors |
08/21/2013 | EP2627635A1 Salts of arylsulfonamide ccr3 antagonists |
08/21/2013 | CN103261165A 胰高血糖素受体调节剂 Glucagon receptor modulators |
08/21/2013 | CN103261164A Neprilysin inhibitors |
08/21/2013 | CN102127056B Tubulin inhibitors |
08/21/2013 | CN102036963B Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors |
08/21/2013 | CN101981015B 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents |
08/20/2013 | US8513415 Preparation of C-pyrazine-methylamines |
08/20/2013 | US8513268 1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy |
08/20/2013 | US8513261 Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide |
08/20/2013 | US8513252 Pyrazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
08/20/2013 | US8513241 3,4-dihydro-2H-pyrazino[1,2-A]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
08/20/2013 | CA2736281C Tri-substituted pyrimidine compounds and their use as pde10 inhibitors |
08/15/2013 | US20130211081 Method for stereoselective synthesis of bicyclic heterocyclic compounds |
08/15/2013 | US20130211076 Method for preparing substituted N-(3-amino-quinoxalin-2-yl)-sulfonamides and their intermediates N-(3-chloro-quinoxalin-2-yl)-sulfonamides |
08/14/2013 | CN103249723A Pyrazine derivatives as enac blockers |
08/14/2013 | CN103249720A Oxime compounds as HDL-holesterol raising agents |
08/14/2013 | CN103242250A Preparation method of 2-quinoxaline methylene hydrazino cyanoacetic acid-N1-oxide |
08/14/2013 | CN103242249A Compound capable of identifying dodecylbenzene sulfonic acid ions as well as preparation method and application thereof |
08/14/2013 | CN103242248A Pyrazine semicarbazide compound as well as preparation method and application thereof |
08/14/2013 | CN103242247A Synthesis and refining method of 2, 5-dihydroxymethyl-3, 6-dimethyl pyrazine |
08/14/2013 | CN103242246A Synthetic method of 3-substituted N-methyl piperazine |
08/14/2013 | CN103242210A Mulin acetate containing substituted squaric acid and application thereof |
08/14/2013 | CN103242167A Amine compound, electrophotographic photoconductor, image forming method, image forming apparatus, and process cartridge |
08/14/2013 | CN102276539B Bacteriostatic compound and preparation method thereof |
08/14/2013 | CN101341135B Substituted pyrazinone derivatives for use in MCH-1 mediated diseases |
08/14/2013 | CN101282946B 半胱氨酸蛋白酶抑制剂及它们的治疗应用 Cysteine protease inhibitors and their therapeutic applications |
08/13/2013 | CA2589748C Heterocyclic compounds as ccr2b antagonists |
08/08/2013 | US20130203988 Process for making bortezomib and intermediates for the process |